Abstract
Cystic echinococcosis (CE) or hydatidosis is a parasitic disease affecting both humans and animals. The present study aimed to evaluate the efficacy of the ELISA test in diagnosis of human hydatidosis using crude protoscolices antigens. Echinococcus granulosus protoscolices were isolated from the human liver hydatid cyst (local strain G1). Their crude antigen was prepared by the sonication technique. One hundred and eight sera samples were collected from patients with hydatid cyst (n = 21), individuals with other infections (n = 27) and sheep breeders (n = 60). These sera were evaluated using the ELISA assay. The predictable rate of sensitivity for the ELISA using the crude antigens was 100% depending on the cut-off. Additionally, the estimated values of specificity, positive and negative predictive values and accuracy were 97.4%; 87.3%; 100% and 97.8%, respectively. Crud E. granulosus protoscolices antigens are considered suitable candidates for the sero-diagnosis of human CE. To identify a single antigen and increase its effectiveness in serologic diagnostic testing, more research on these antigens is needed.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-025-17798-1.
Keywords: Echinococcus granulosus, Hydatidosis, Syria, Protoscolex, ELISA
Subject terms: Immunology, Microbiology, Diseases
Introduction
Cystic echinococcosis (CE) or hydatidosis caused by Echinococcus granulosus, is a neglected parasitic disease with worldwide distribution, mostly affecting all countries of the Middle East1,2. An adult worm of E. granulosus lives in the small intestine of the carnivores as a definitive host. However, the metacestodes develop as hydatid cysts, in the internal viscera (e.g., liver, lungs…etc.) in herbivores and humans (intermediate host) after consuming the food contaminated with worms’ eggs. These cysts contain daughter cysts, protoscolices and antigens belonging to the parasite and host3.
Imaging techniques are still one of the most useful tools to identify the cyst in the body, but they are not able to differentiate the cyst from benign or malignant tumors4,5. Different immunological methods, including an indirect hemagglutination test (IHA), a complement fixation test (CFT), an immunofluorescence assay (IFA), western blotting, and an enzyme-linked immunosorbent assay (ELISA), are the most common methods used for the specific diagnosis of CE6,7.
E. granulosus antigens, such as crude antigen (CA), protoscolex antigens (PA), native and recombinant B antigen, have been utilized for the diagnosis of CE8. Antigen B is considered the most important antigen, which is produced by protoscolex coat cells and is one of the most abundant parasitic antigens present in hydatid cyst fluid9. Consequently, WHO recommended the preparation of native B antigens for use in the diagnosis of this disease and reliance on antigens derived from protoscolices antigen instead of hydatid fluid antigen in diagnosis mainly by ELISA10.
The present study aimed to evaluate the efficacy of the ELISA, using Echinococcus protoscolices antigens, for the diagnosis of human CE.
Materials and methods
Ethics approval and informed consent
The study was approved by the Institutional Review Board and Ethics Committee on Human Research of Damascus University (#2656/2023) before its commencement. A written informed consent was obtained from all patients participating in the study, or their parents or legal guardians.
Protoscolex antigen Preparation
Antigen was prepared from protoscolices derived from human hydatid cyst in the liver, previously sequenced and deposited in GenBank under accession number (PP385946.1). Under the aseptic conditions, the aspirated protoscolices from the hydatid cyst fluid were washed three times with PBS buffer and examined by a light microscope and 0.1% eosin (Sigma-Aldrich, Louis, MO, USA) staining to assess their viability. A crude antigen was prepared as the following: protoscolices were lysed in 500 µl lysis buffer (150 mM NaCl, 10 mM TrisHcl, 1 mM EDTA, 0.1 mM Nonidet p40) after adding the protease kinase inhibitor and serine protease inhibitor, then sonicating (8 cycles/15 sec) using a 200w ultrasonic disintegrator (Hielscher UP200St; Germany) until no intact protoscolices was visible in microscope. The sample was standing for one hour then centrifuged at 14,000 g for 10 min at 4 °C. After filtering the supernatant, protoscolices total proteins (PSCsTP) concentration was estimated by Bradford method11. Antigen was aliquoted into 0.5 ml microtubes and stored at −20 C until further processing.
Human serum samples
Forty-eight blood samples were collected from National University Hospital patients for digestive disturbances, abdominal pain and fever. The blood samples were divided into two groups:
Gr 1: Twenty-one samples (7 males and 14 females), used as positive control, were collected from hydatidosis (13 single/8 multiple cysts in liver “n = 18” and lungs “n = 3”) surgically proven patients (the cysts size varied between 6.5 and 15 cm).
Gr 2: Twenty-seven samples (14 males and 13 females) were collected from patients with other diseases: visceral leishmaniasis (n = 2), toxoplasmosis (n = 2), blastocystosis (n = 2) and colorectal cancer patients (n = 21). The samples were used as negative controls after CT scans were performed on these patients to rule out hydatid disease.
Sixty sporadic samples (43 males and 17 females) were collected from sheep breeders and their families who are in direct contact with dogs, from eastern Damascus Suburb.
The age of the participants in this study ranged between 14 and 65 years old. All blood samples were allowed to clot for serum separation, aliquoted and stored at −20 C until used.
ELISA test
Each serum sample was tested for anti-Echinococcus antibodies in an ELISA. In Brief, an ELISA plate was sensitized with PSCsTP antigen (0.1 µg/well) diluted in coating buffer (PBS, pH = 6) and incubated overnight at 4 °C. They were washed three times by.
PBS-T20 buffer and dried completely. Two hundred microliters of blocking solution (5% skimmed milk in PBS, pH = 6) were added to each well and the microplates were incubated at RT for 1 to 2 h. After three washes, 100 µl of diluted serum samples were loaded into each well (at a dilution of 1:10 in PBS containing 1% skimmed milk) and incubated at RT for 1 h. After washing, Alkaline Phosphatase rabbit anti-human was added at a dilution of 1:2000 into all the wells and incubated for 1 h at RT. After three washes to remove the excess conjugate, 50 µl per well AP substrate (p-Nitrophenyl Phosphate (pNPP) & 0.02%, hydrogen peroxide) was added and incubated at RT for 45 min in the dark. Finally, the absorbance density (OD) was registered at 405 nm by ELISA reader (Thermo Scientific™ Multiskan™ GO, USA) after the addition of 50 µl per well of stop solution (0.2 M H2SO4). The cutoff value was calculated by an average of negative control OD value + 3 standard deviation (SD).
Statistical analysis
The input data of samples and ELISA results were analyzed by SPSS (version 26 software) to evaluate the descriptive study’s Chi-square and ROC tests. MedCalc software Ltd was used to verify the accuracy of the assay. GraphPad Prism (version 8.0.1) was used to present the data.
Results
The viability of protoscolices, from local strain of human-cyst origin, using the light microscope (Olympus CX21 Japan), reached 95% (Fig. 1, a). Quality analysis of the prepared E. granulosus protoscolices antigen using SDS-PAGE (Fig. 1, b) showed that the extracted protein (with concentration ranging between 1 and 5 µg/µL) was of high quality and could be used in an ELISA assay.
Fig. 1.
Human protoscolices hydatid cyst. a. High number of live protoscolices under microscope (magnification x10), dead protoscolex (red). b. Electrophoresis of protoscolices proteins using 12% SDS-PAGE gel stained with Coomassie blue dye. M: molecular weight standard, PSCsTP: crude protoscolices protein.
When the crude E. granulosus protoscolices protein (PSCsTP) was used in an ELISA test to detect anti-Echinococcus antibodies, taking into consideration the calculated cut off (0.213), a total of 21 (100%) serum samples from group 1, were positive (OD = 0.386 ± 0.015). No significant relation between OD intensity and the number of hydatid cysts or its site (P = 0.496; P = 0.489 respectively) were observed. However, this test was not specific enough, because cross reaction was observed with sera pertaining to blastocystosis (2/27; 7.4%) while no cross reactions occurred with serum samples from patients infected with colon tumors (OD = 0.177 ± 0.003), leishmaniasis and toxoplasmosis (OD = 0.189 ± 0.004) (Fig. 2, a). However, only 9/60 (15%) of serum samples from group 3 (6 males and 3 females) revealed positive reaction (Fig. 2, b).
Fig. 2.
a: PSCs-ELISA sensitivity and specificity optimization depending on group 1 as positive control (red above the cut off line) and group 2 as negative control (blue below the cut off line). Cut off = 0.213. b: PSCs-ELISA screening test for all serum groups. Positive (red), other parasite/cancer patients’ serum (Negative: blue; cross reaction: green), and sheep breeder sera (purple). Cut off = 0.339.
The age of these seropositive cases ranged between 15 and 34 and 35–64 years old (Table 1). No significant relation was observed between the infected cases and the demographic features.
Table 1.
Demographic features of the studied groups.
| Features | Gr 1 | Gr 2 | Gr 3 | Total | P value | ||||
|---|---|---|---|---|---|---|---|---|---|
| Gender | |||||||||
|
Female N (%) |
Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | 0.089 |
| 0 |
14 (66.7%) |
13 (48.1%) |
0 |
14 (23.3%) |
3 (5%) |
27 (25%) |
17 (15.7%) |
||
|
Male N (%) |
Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | |
| 0 |
7 (33.3%) |
12 (44.4%) |
2 (7.4%) |
37 (61.7%) |
6 (10%) |
49 (45.4%) |
15 (13.9%) |
||
| Age (Years) | |||||||||
|
< 14 N (%) |
Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | 0.976 |
| 0 |
3 (14.3%) |
0 | 0 |
7 (11.7%) |
0 |
7 (6.5%) |
3 (2.8%) |
||
|
15–34 N (%) |
Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | |
| 0 |
4 (19.0%) |
0 | 0 |
12 (20%) |
1 (1.7%) |
12 (11.1%) |
5 (4.6%) |
||
|
35–64 N (%) |
Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | |
| 0 |
12 (57.1%) |
15 (55.6%) |
0 |
30 (50%) |
8 (13.3%) |
45 (41.7%) |
20 (18.5%) |
||
|
> 65 N (%) |
Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | |
| 0 |
2 (9.5%) |
10 (37%) |
2 (7.4%) |
2 (3.3%) |
0 |
12 (11.1%) |
4 (3.7%) |
||
The estimated values of sensitivity and specificity for the protoscolices antigens in the ELISA were 100% (95% CI: 88.43–100.00%), 97.44% (95% CI: 91.04–99.7%), respectively. As well, its accuracy was 97.82% (Table 2). ROC test illustrated a good value for AUC = 0.896 (81.7–97.5%).
Table 2.
The sensitivity, specificity, PPV, NPV and accuracy of ELISA using protoscolices antigens.
| Statistic | Value | 95% CI |
|---|---|---|
| Sensitivity | 100.00% | 88.43–100.00% |
| Specificity | 97.44% | 91.04–99.69% |
| Positive Predictive Value (PPV) | 87.31% | 63.67–96.43% |
| Negative Predictive Value (NPV) | 100.00% | 95.26–100.00% |
| Accuracy | 97.82% | 92.97–99.66% |
Discussion
Human CE is one of the endemic neglected diseases in our region which spreads in rural areas where individuals are in direct contact with dogs and livestock12,13. Imaging techniques are the most reliable method for diagnosis of CE. Serological tests are still needed to approve positive cases, but their efficacy is insufficient. Therefore, the development of the suitable serological method is needed for diagnosing this disease.
Although there are differences between antigens extracted from adult worms and from protoscolex, it has been demonstrated that these antigens, which have similar sensitivity and specificity, can be used in diagnosis of hydatid disease in different hosts7,14. Many previous studies showed the importance of using the antigen extracted from E. granulosus protoscolices obtained from the sheep hydatid cyst in serological tests such as ELISA, IFA and latex agglutination test for the diagnosis of human CE8.
Our results revealed a high sensitivity of protoscolices antigen, extracted from human local strain, reaching 100% by using ELISA for diagnosing the human hydatidosis. This finding is comparable to ELISA and WB data (100% for each) previously obtained14,15. Nevertheless, it disagrees with others that reported low sensitivity by using protoscolices for the primary sero-diagnosis of CE16,17.
The analysis of sera from patients infected with parasitic diseases or with colorectal cancer showed an overall specificity of 97.4%, due to cross-reactivity with sera from patients infected with blastocystosis. This result is slightly higher than the earliest findings that have shown cross-reactivity with sera from patients infected with non-CE parasitic diseases (such as fascioliasis and toxoplasmosis) or autoimmune diseases8,16. Our data may be attributed to the origin of used strain (human or animal) and to the method of preparing the protoscolices antigens.
Additionally, our study revealed 9 out of 60 (15%) of asymptomatic individuals who were seropositive for anti-HC-IgG-antibodies (anti-HC-Abs). This finding is in line with studies conducted on random human serum samples in Egypt, Iran, and Iraq (54.8%, 18.4%, 5.1%, respectively)14,18,19. This can be likely caused by contamination either with Echinococcus eggs when contacting dogs or by consuming raw meat when slaughtering sheep in people’s residences17.
Moreover, our data revealed a high rate of infection with CE in females than in males. This result is in line with previous findings in neighboring countries17,20–22. This result may be associated with the lifestyle of women in rural areas and to the effect of female hormones on the immune response to Echinococcus infection23,24. Furthermore, two age groups (15–34 years and 35–64 years) of patients showed a high rate of infection with CE. This finding is comparable to many earlier studies, which showed a relationship between age and the incidence of hydatid disease and reported a high rate among individuals aged between 12 and 50 years20,21,25. Finally, in this study, there is a limitation concerning other factors about CE (such as: stage, age, location of cyst) which have an impact on the variability of ELISA results.
Conclusion
Findings of the current study demonstrate that the E. granulosus protoscolices antigens, from local human origin strain (G1), are an excellent candidate for the sero-diagnosis of human cystic echinococcosis. Future studies are needed to identify a single specific antigen among the protoscolices antigens to improve the diagnostic performance of it.
Supplementary Information
Below is the link to the electronic supplementary material.
Acknowledgements
The authors gratefully acknowledge Dr. Rasheed Abdul Hadi for proofreading, as well as Ahmad Farhouda and Nour Damer for serum samples collecting.
Author contributions
D. S. : sample collection, performing lab experiments and data analysis. H. Ch.: resection of hydatid cysts. AQ. A. and S. Al N. : project design, data analysis, writing and revising the manuscript. All authors reviewed the manuscript.
Funding
The study was conducted with financial assistance from Damascus University (funder No. 501100020595).
Data availability
All results obtained during the current study are included in this article and are available from the corresponding author upon reasonable request.
Declarations
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Borhani, M. et al. Echinococcoses in iran, turkey, and pakistan: old diseases in the new millennium. Clin. Microbiol. Rev.34 (3), e0029020. 10.1128/CMR.00290-20 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Zhang, X. et al. Brief report prevalence of Echinococcus species in wild foxes in parts of Qinghai province, China. Vet. Res. Commun.47 (2), 947–952. 10.1007/s11259-022-10012-x (2023). [DOI] [PubMed] [Google Scholar]
- 3.Tamarozzi, F., Legnardi, M., Fittipaldo, A., Drigo, M. & Cassini, R. Epidemiological distribution of Echinococcus granulosus s.l. Infection in human and domestic animal hosts in European mediterranean and Balkan countries: A systematic review. PLoS Negl. Trop. Dis.14 (8), e0008519. 10.1371/journal.pntd.0008519 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Siles-Lucas, M., Casulli, A., Conraths, F. J. & Muller, N. Laboratory diagnosis of Echinococcus spp. In human patients and infected animals. Adv. Parasitol.96, 159–257. 10.1016/bs.apar.2016.09.003 (2017). [DOI] [PubMed] [Google Scholar]
- 5.Elaadli, H., El Adly, H., Shaapan, R. M. & Bessat, M. An uncommon primary Splenic hydatid cyst in human: A case report study. Egypt. J. Hosp. Med.89, 5493–5497. 10.1111/j.1863-2378.2008.01200.x (2022). [Google Scholar]
- 6.Hadipour, M. et al. Immunological diagnosis of human hydatid cyst using Western Immunoblotting technique. J. Res. Med. Sci.21, 130. 10.4103/1735-1995.196612 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Maher, A. et al. Human and camel cystic echinococcosis - a polyclonal antibody-based sandwich ELISA for its serodiagnosis with molecular identification. Vet. Res. Commun.48 (4), 2193–2206. 10.1007/s11259-024-10375-3 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Shahabinejad, P. et al. Diagnostic performance of Echinococcus granulosus protoscolices antigens in the serodiagnosis of human cystic echinococcosis. J. Immunoass. Immunochem. 41 (5), 833–840. 10.1080/15321819.2020.1781653 (2020). [DOI] [PubMed] [Google Scholar]
- 9.Rosenzvit, M. C., Camicia, F., Kamenetzky, L., Muzulin, P. M. & Gutierrez, A. M. Identification and intra-specific variability analysis of secreted and membrane-bound proteins from Echinococcus granulosus. Parasitol. Int.55 Suppl, 63–67. 10.1016/j.parint.2005.11.009 (2006). [DOI] [PubMed] [Google Scholar]
- 10.WHO & Echinococcosis (2021). https://www.who.int/news-room/fact-sheets/detail/echinococcosis
- 11.Kielkopf, C. L., Bauer, W. & Urbatsch, I. L. Bradford assay for determining protein concentration. Cold Spring Harb Protoc.2020 (4), 102269. 10.1101/pdb.prot102269 (2020). [DOI] [PubMed] [Google Scholar]
- 12.Sadjjadi, S. M. Present situation of echinococcosis in the middle East and Arabic North Africa. Parasitol. Int.55 Suppl, S197–202. 10.1016/j.parint.2005.11.030 (2006). [DOI] [PubMed] [Google Scholar]
- 13.Dakkak, A. Echinococcosis/hydatidosis: a severe threat in mediterranean countries. Vet. Parasitol.174 (1–2), 2–11. 10.1016/j.vetpar.2010.08.009 (2010). [DOI] [PubMed] [Google Scholar]
- 14.Hassanain, M. A. et al. Immunological detection of human and camel cystic echinococcosis using different antigens of hydatid cyst fluid, protoscoleces, and germinal layers. Vet. World. 14 (1), 270–275. 10.14202/vetworld.2021.270-275 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Maglioco, A. et al. Detection of Echinococcus granulosus sensu Lato infection by using extracts derived from a Protoscoleces G1 cell line. Parasite Immunol.41 (12), e12674. 10.1111/pim.12674 (2019). [DOI] [PubMed] [Google Scholar]
- 16.Mohammadzadeh, T., Sako, Y., Sadjjadi, S. M., Sarkari, B. & Ito, A. Comparison of the usefulness of hydatid cyst fluid, native antigen B and Recombinant antigen B8/1 for serological diagnosis of cystic echinococcosis. Trans. R Soc. Trop. Med. Hyg.106 (6), 371–375. 10.1016/j.trstmh.2012.01.012 (2012). [DOI] [PubMed] [Google Scholar]
- 17.Heidari, Z. et al. Seroprevalence of human hydatidosis in ardabil province, North-West of Iran. Iran. J. Parasitol.16 (4), 593–600. 10.18502/ijpa.v16i4.7872 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Sarkari, B., Sadjjadi, S., Beheshtian, M., Aghaee, M. & Sedaghat, F. Human cystic echinococcosis in Yasuj district in Southwes of iran: an epidemiological study of Seroprevalence and surgical cases over a Ten-year period. Zoonoses Public. Health. 57, 146–150. 10.1111/j.1863-2378.2008.01200.x (2008). [DOI] [PubMed] [Google Scholar]
- 19.Hama, A. A., Mero, W. M. S. & Jubrael, J. Sero-prevalence and Incidence rate of Hydatid Disease in Sulaimani Province/Kurdistan-Iraq. Cihan University. (2014). 10.13140/2.1.3689.9200
- 20.Himsawi, N., Hijjawi, N., Al-Radaideh, A. & Al-Tamimi, M. Seroprevalence of cystic echinococcosis in a high-risk area (Al-Mafraq Governorate) in jordan, using indirect hemagglutination test. Parasite Epidemiol. Control. 5, e00104. 10.1016/j.parepi.2019.e00104 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Al-Saimary, I., Al-Shemari, M. & Al-Fayadh, M. Epidemiological and immunological findings on human hydatidosis. Int. Scholars Journals. 8 (5), 001–009 (2020). [Google Scholar]
- 22.Erganis, S., Sarzhanov, F., Al, F. D. & Caglar, K. Comparison of methods in the serologic diagnosis of cystic echinococcosis. Acta Parasitol.69 (2), 1122–1131. 10.1007/s11686-024-00840-z (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Roberts, C. W. & Horsnell, W. G. C. Effects of Sex and Maternal Immunity on Protozoan and Helminth Infections. In. (2015). 10.1007/978-3-319-16438_13
- 24.Ebrahimipour, M., Rezaeian, S., Shirzadi, M. R. & Barati, M. Prevalence and risk factors associated with human cystic echinococcosis in Iran. J. Parasit. Dis.43 (3), 385–392. 10.1007/s12639-019-01102-w (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hussien, S., Ibrahim, E. E., saadawy, A. L. & Salama, B. A. S. K., Seroprevalence and Epidemiological Overview of Human cystic Echinococcosis in Egypt. INT-JECS, 14(03 (2022). 10.9756/INT-JECSE/V1413.235 (2022).
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All results obtained during the current study are included in this article and are available from the corresponding author upon reasonable request.


